Quantcast

Latest Prostate-specific antigen Stories

2014-03-24 16:22:35

NORWALK, Conn., March 24, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the online home of the journal ONCOLOGY presents a special report on the most prevalent cancer for men, prostate cancer. Cancer Network, a leading online community for oncologists and others who treat cancer, offers news, blogs, and podcasts about the latest clinical findings and best practices in oncology. As part of our special series on prostate cancer, we present: -- An interview with...

2014-03-03 16:23:09

Very small sample-size study incapable of showing cause-and-effect relationship WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) offers the following comments regarding the study published today in PLOS ONE by the Cincinnati Cancer Center researchers Pheruza Tarapore, et al. Quotes from the following may be attributed to Steven G. Hentges, Ph.D. of ACC's Polycarbonate/BPA Global Group. "Cancer touches the lives of far too many, and...

2014-02-26 12:25:59

New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb. 26, 2014 /PRNewswire-USNewswire/ -- Northwestern Medicine(®) is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test's accuracy will effectively remove the...

2014-01-10 08:23:58

Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan. 10, 2014 /PRNewswire/ -- Studies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence. Now, researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood...

2014-01-07 10:42:10

Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated, according to a new study published January 6 in the Journal of the National Cancer Institute. The authors used a standard definition of overdiagnosis to refer to a cancer that would not have become symptomatic or clinically identifiable if it had not been detected by screening....

2014-01-07 08:31:48

LOS ANGELES, Jan. 7, 2014 /PRNewswire/ -- Interim results from a clinical trial of Prostate Health Cocktail (PHC®) show promise that OncoNatural's over-the-counter dietary supplement may soon become a widely recognized adjunct treatment for prostate disease. Prostate specific antigen, or PSA, was effectively stabilized in more than 83% of study participants. Equally important, PHC demonstrated far less impact on quality of life and physical wellbeing metrics when compared with traditional...

2013-10-14 09:20:41

A new study reveals that in the prediction of treatment outcome for castration-resistant prostate cancer, a change in circulating tumor cells detection might be more accurate than the change in prostate-specific antigen levels. The findings of this award-winning study were presented at the recent EAU 13th Central European Meeting in Prague. "The research of the circulating tumor cells (CTC) is of utmost importance, because nowadays there is no reliable marker of both cancer-specific or...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.